Taken together, these data suggest that HIF2α, but not HIF1α, mediates hypoxia-induced breast cancer growth and that EFEMP1 promotes BCSC renewal and tumor metastasis as a downstream effector of hypoxia-induced HIF2α during breast tumorigenesis. Here, HIF1A is linked to breast carcinoma.